Navigation Links
Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
Date:6/19/2008

EMERYVILLE, Calif., June 19 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Jefferies 2nd Annual Healthcare Conference on Thursday, June 26, at 10:45 a.m. Eastern Time. Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx-pharm.com/wt/page/event_calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through July 26, 2008.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer, and other cancers. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
2. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
3. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
4. GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
5. Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
6. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
8. Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.
9. Celator(R) Pharmaceuticals to Present at 2008 BIO International Convention
10. Scimitar Equity, LLC Initiates Coverage Review of VioQuest Pharmaceuticals, Inc.
11. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCa... "Company") (TSX:ONC; NASDAQ: ONCY ) announced tod...d unit offering, the underwriters have exercised i...n additional 637,500 units. Each unit is comprised...chase warrant, and was sold at a price of US$3.00 ...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /...bility study evaluating the preclinical (animal st... which combines technology from Weill,Cornell Medi...potential to,treat inherited anemias such as Coole... series of technologies to expand, ex vivo,popula...
(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/...) (the "Company"), a global biopharmaceutical comp...ay announced that the U.S. Food and Drug Administr... the Company,s PI3K/Akt pathway inhibitor compound...psed/refractory multiple myeloma. Keryx Biopharmac...
(Date:12/1/2009)... Dr. Kerry Solomon announced ... has launched his redesigned website at www.DrKer...sulting Group. Dr. Solomon is a proven LASIK, len...n professionally recognized for his substantial co.... He is a member of Trusted LASIK Surgeons, which...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...expressed concern to Department of Health and Huma...ay impede clinical research trials. , ,Institution...eview and approve thousands of patient authorizati...ng to a letter from Stan Crosley, chief privacy of...sponse letter, Richard Campanelli, director of the...
...f the nearly $60 billion acquisition of Pharmacia ...wig out the door is Dr. Gran Ando, who headed up P...pment operations. Today, Celltech, one of Europe,s...s its new chief executive. , ,"You will see that t...g Pfizer," Ando says. "They only need one CEO, one...
...er of browser-based policy, claims, and billing ad...ystem allows business users to maintain much of th...ive technical resources are conserved. The combina...ns enables companies to automate customer communic...le enhancing the efficiency of business operations...
Other Biology Technology:Pfizer-Pharmacia Fallout Gives Celltech A CEO 2
(Date:12/2/2009)...HORES, Calif. and PALM HARBOR, Fla., Dec. 2 /PRNew...poration ("CIC") (OTC Bulletin Board: CICI), a lea...r business process automation in the financial ind...gnature verification and Docubase Systems Inc. ("D...ment Management (EDM) software provider announced ...
(Date:12/2/2009)...rsity of Salamanca and another from Yale Universit...s the behaviour of Acanthodactylus beershebensis ...ar East. According to the study, these reptiles mo...f they are under pressure from predators. , Many... until now there had been very few experimental tr...
(Date:12/1/2009)...tional Primate Research Center, Emory University, ...rairie voles, an important step toward unlocking t...plication of this technology will enable scientist...will help identify the brain mechanisms of social ...dvancement may also have important implications fo...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Lizards change their diet to avoid predators 2Yerkes researchers create first transgenic prairie voles 2ETEX Corporation Announces Additional FDA Clearance For EquivaBone 28R 29 The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substi 5166 1ETEX Corporation Announces Additional FDA Clearance For EquivaBone 28R 29 The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substi 5166 2Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimers 58690 1Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimers 58690 2Natural killer cells keep immune system in balance 10226 1Natural killer cells keep immune system in balance 10226 2
... in bioengineering, imaging, molecular genetics, i...r biology to collaborate on Proposition 71 researc...se as engineering to molecular biology, UCLA offic...tute for Stem Cell Biology and Medicine to conduct...ead to better treatments for HIV, cancer and neuro...
...re a cat fancier, you,re well aware that hair foll... mutation that caught a cat breeder,s eye, le chat...coat consists of little more than a ridge of fur d... thrive as a pet. Hairless animals in the lab, on ...ding how hair develops sheds light on the fundamen...
...r of articles explore the use of positron emission...gical techniques that open the door to understandi... of the Society of Nuclear Medicine,s Journal of N... imaging "is the ability to carry out many studies...d SNM member Michael J. Welch, Ph.D., co-author of...
Other Biology News:UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders 2UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders 3UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders 4Hirsute Or Hairless? Two Proteins May Spell The Difference 2Hirsute Or Hairless? Two Proteins May Spell The Difference 3Use of PET can reduce, may eliminate more strenuous drug development trials with animals 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 3Use of PET can reduce, may eliminate more strenuous drug development trials with animals 4
...cultured in Ham's F12K medium with 2 mM L-glutamin...er to keep the antigens in their native forms, cel...rrayed on a 12-well (5 mm) adhesive coated slide, ...hance cellular attachment and to minimize backgrou...
BD Falcon cultivation flask from BD Biosciences - Discovery Labware
Mouse Anti-PSD-95, PDZ Domain Monoclonal Antibody, Unconjugated, Clone K28/86.2 from Upstate
...ecifically for western blots ,• Optically c...ly designed for staining western blots. The reduce...quires less dye and antibodies resulting in a sign...ach corner facilitate pouring of liquid. Optically...
Biology Products: